Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk (2023)

First Author: Davies C

Attributed to: CANNABIDIOL AS A NOVEL THERAPEUTIC AGENT FOR PATIENTS AT ULTRA HIGH-RISK OF PSYCHOSIS: AN EXPERIMENTAL MEDICINE APPROACH funded by MRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Schizophrenia Bulletin Open

Issue: 1